Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The intestinal microbiota plays an important role in the pathogenesis of Clostridioides difficile-associated diarrhea, and regional and racial characteristics influence the microbiome composition and diversity. We investigated the intestinal microbiome characteristics of patients with C. difficile colitis (CD+) compared to those of patients with colitis not due to C. difficile (CD−), patients with vancomycin-resistant enterococci (VRE) colonization, and healthy controls, in Korea. Materials and Methods: We collected stool samples from 24, 18, 11 and 13 subjects within CD+, CD−, VRE and healthy control groups, respectively. The microbial communities were evaluated by 454-pyrosequencing of bacterial 16s rRNA. Results: The species richness and microbial diversity were significantly lower in the CD+ group compared to those in healthy controls, but not compared to those in CD− and VRE groups. Phylum-level analysis showed that the proportion of Actinobacteria in the CD+ group was significantly lower than in the healthy control, but was unchanged compared to that in CD− and VRE groups. At the genus level, compared to the healthy group, the CD+ group showed significantly lower proportions of Blautia, Bifidobacterium, Faecalibacterium et al. Compared to the VRE group, the CD+ group showed a significantly higher proportion of Anaerostipes. Conclusions: We could identify the intestinal microbiome characteristics of Koreans with C. difficile colitis. It might help to develop microbiome based diagnostic and treatment modalities.
Abstract
Background: The intestinal microbiota plays an important role in the pathogenesis of Clostridioides difficile-associated diarrhea, and regional and racial characteristics influence the microbiome composition and diversity. We investigated the intestinal microbiome characteristics of patients with C. difficile colitis (CD+) compared to those of patients with colitis not due to C. difficile (CD−), patients with vancomycin-resistant enterococci (VRE) colonization, and healthy controls, in Korea. Materials and Methods: We collected stool samples from 24, 18, 11 and 13 subjects within CD+, CD−, VRE and healthy control groups, respectively. The microbial communities were evaluated by 454-pyrosequencing of bacterial 16s rRNA. Results: The species richness and microbial diversity were significantly lower in the CD+ group compared to those in healthy controls, but not compared to those in CD− and VRE groups. Phylum-level analysis showed that the proportion of Actinobacteria in the CD+ group was significantly lower than in the healthy control, but was unchanged compared to that in CD− and VRE groups. At the genus level, compared to the healthy group, the CD+ group showed significantly lower proportions of Blautia, Bifidobacterium, Faecalibacterium et al. Compared to the VRE group, the CD+ group showed a significantly higher proportion of Anaerostipes. Conclusions: We could identify the intestinal microbiome characteristics of Koreans with C. difficile colitis. It might help to develop microbiome based diagnostic and treatment modalities.
참고문헌 (40)
- Hooper LV, "How host-microbial interactions shape the nutrient environment of the mammalian intestine", Annu Rev Nutr, 22, pp.283~307 (2002)
- Kinross JM, "Gut microbiome-host interactions in health and disease", Genome Med, 3, pp.14~ (2011)
- Mueller S, "Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study", Appl Environ Microbiol, 72, pp.1027~1033 (2006)
- Yatsunenko T, "Human gut microbiome viewed across age and geography", Nature, 486, pp.222~227 (2012)
- Dave M, "The human gut microbiome: current knowledge, challenges, and future directions", Transl Res, 160, pp.246~257 (2012)
- Distrutti E, "Gut microbiota role in irritable bowel syndrome : New therapeutic strategies", World J Gastroenterol, 22, pp.2219~2241 (2016)
- Patterson E, "Gut microbiota, obesity and diabetes", Postgrad Med J (2016)
- Singh V, "Gut microbiome as a novel cardiovascular therapeutic target", Curr Opin Pharmacol, 27, pp.8~12 (2016)
- Seekatz AM, "Clostridium difficile and the microbiota", J Clin Invest, 124, pp.4182~4189 (2014)
- Kelly CP, "Clostridium difficile--more difficult than ever", N Engl J Med, 359, pp.1932~1940 (2008)
- McFarland LV, "Breaking the cycle : treatment strategies for 163 cases of recurrent Clostridium difficile disease", Am J Gastroenterol, 97, pp.1769~1775 (2002)
- van Nood E, "Duodenal infusion of donor feces for recurrent Clostridium difficile", N Engl J Med, 368, pp.407~415 (2013)
- Almeida R, "Recurrent Clostridium difficile infection and the microbiome", J Gastroenterol, 51, pp.1~10 (2016)
- Rupnik M, "Toward a true bacteriotherapy for Clostridium difficile infection", N Engl J Med, 372, pp.1566~1568 (2015)
- 문강륜, "관장을 통한 대변 이식으로 완치된 치료 저항성 및 반복적 Clostridium difficile 감염", Annals of geriatric medicine and research, 17(3), pp.152~156 (2013), 대한노인병학회
- Sun-Young Kook, "Characterization of the fecal microbiota differs between age groups in Koreans", Intestinal research, 16(2), pp.246~254 (2018), 대한장연구학회
- Shin JH, "Differential Effects of Typical Korean Versus American-Style Diets on Gut Microbial Composition and Metabolic Profile in Healthy Overweight Koreans: A Randomized Crossover Trial", Nutrients, 11, pp.pii: E2450~ (2019)
- Safdar N, "The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida", Ann Intern Med, 136, pp.834~844 (2002)
- Özsoy S, "Detection of vancomycin-resistant enterococci(VRE)in stool specimens submitted for Clostridium difficile toxin testing", Braz J Microbiol, 48, pp.489~492 (2017)
- Ray AJ, "Undetected vancomycin-resistant Enterococcus stool colonization in a Veterans Affairs Hospital using a Clostridium difficile-focused surveillance strategy", Infect Control Hosp Epidemiol, 23, pp.474~477 (2002)
- Kyne L, "Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile", Clin Infect Dis, 34, pp.346~353 (2002)
- Zar FA, "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity", Clin Infect Dis, 45, pp.302~307 (2007)
- Kato H, "Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR", J Clin Microbiol, 36, pp.2178~2182 (1998)
- Kwon SS, "Clinical and molecular characteristics of community-acquired Clostridium difficile infections in comparison with those of hospital-acquired C. difficile", Anaerobe, 48, pp.42~46 (2017)
- Chun J, "The analysis of oral microbial communities of wild-type and toll-like receptor 2-deficient mice using a 454 GS FLX Titanium pyrosequencer", BMC Microbiol, 10, pp.101~ (2010)
- Hur M, "Effect of genetically modified poplars on soil microbial communities during the phytoremediation of waste mine tailings", Appl Environ Microbiol, 77, pp.7611~7619 (2011)
- Kim BS, "Impact of enrofloxacin on the human intestinal microbiota revealed by comparative molecular analysis", Anaerobe, 18, pp.310~320 (2012)
- Huber T, "Bellerophon : a program to detect chimeric sequences in multiple sequence alignments", Bioinformatics, 20, pp.2317~2319 (2004)
- Kim OS, "Introducing EzTaxon-e : a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species", Int J Syst Evol Microbiol, 62, pp.716~721 (2012)
- Hamady M, "Fast UniFrac : facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data", ISME J, 4, pp.17~27 (2010)
- Milani C, "Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals : a metagenomic study", Sci Rep, 6, pp.25945~ (2016)
- Zhang L, "Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization", Anaerobe, 34, pp.1~7 (2015)
- Han SH, "Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load", PLoS One, 14, pp.e0212626~ (2019)
- Donskey CJ, "Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients", N Engl J Med, 343, pp.1925~1932 (2000)
- Ubeda C, "Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans", J Clin Invest, 120, pp.4332~4341 (2010)
- Smits LP, "Therapeutic potential of fecal microbiota transplantation", Gastroenterology, 145, pp.946~953 (2013)
- Sohn KM, "Can Fecal microbiota transplantation (FMT) eradicate fecal colonization with vancomycin-resistant enterococci (VRE)?", Infect Control Hosp Epidemiol, 37, pp.1519~1521 (2016)
- Manges AR, "Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens : a review", Infect Dis(Lond), 48, pp.587~592 (2016)
- Bar-Yoseph H, "Natural history and decolonization strategies for ESBL", carbapenem-resistant Enterobacteriaceae carriage : systematic review and meta-analysis, 2016, pp.71, 2729~2739
- Buffie CG, "Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile", Nature, 517, pp.205~208 (2015)